Christopher Grant Doughty insider trades

Open-market stock purchases and sales by Christopher Grant Doughty, Chief Business Officer at Crescent Biopharma, Inc, from SEC Form 4 filings since Dec 15, 2025.

Recent trades

DateStockTradeValue
Dec 15, 2025CBIO Crescent Biopharma, IncBought (not open market)—
Dec 15, 2025CBIO Crescent Biopharma, IncBought (not open market)—
Dec 15, 2025CBIO Crescent Biopharma, IncBought (not open market)—

Companies traded

  • CBIO Crescent Biopharma, Inc: other filings, last Dec 15, 2025

Get free alerts when Christopher Grant Doughty files a new trade →